— A Founders Note Part 2

Today, I took a moment to verify Block 170—the first-ever recorded Bitcoin transaction—from our own Canurta Bitcoin node. It was a simple yet historic transfer of 10 BTC from Satoshi Nakamoto to Hal Finney, but its significance extends far beyond its numeric value.

Experiencing this directly, without intermediaries, felt like stepping into a new kind of wilderness—one governed by decentralization, transparency, and immutable truth. It took me back to my days at the University of Kent in Canterbury, where I first encountered the idea of the "state of nature". Historically, when humanity emerged from the wild, the rule of law was essential in building just societies capable of innovation and lasting prosperity.

Today, we find ourselves at the threshold of another "state of nature"—the digital state of nature. Just as human society once relied on law to guide and nurture civilization, this new digital world requires its own guiding principles. In the digital state of nature, decentralization, trustless verification, and incorruptible transparency must form the foundation upon which we build.

At Canurta, we are deliberately embracing this philosophical intersection of decentralization and biotechnology. By harnessing nature's profound innovations and coupling them with Bitcoin's decentralized principles, we forge a path that not only sustains our company but revolutionizes how innovation in human and animal health is financed and realized.

My undergraduate studies at the University of Ottawa in psychology and philosophy further shaped my perspective on how innovation, human behavior, and ethics intertwine. These disciplines taught me that sustainable innovation thrives best in an environment grounded in truth, transparency, and decentralized governance.

This is our unique commitment at Canurta—to unlock nature's power, guided by decentralized truth and verifiable digital energy, to fundamentally transform health outcomes.

We’re just getting started, but this is exactly the future we're ready to build.

— Akeem Gardner

CEO, Canurta Therapeutics

April 30, 2025